Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Markers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02974764
What this trial is testing

Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Neoplastic Cells, CirculatingPancreatic CancerBiological Markers
Johns Hopkins University 200
Not applicableUnknownNCT04800497
What this trial is testing

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

Who this might be right for
Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaCirculating Tumor Cell
University of Milano Bicocca 70
Not applicableUnknownNCT04188275
What this trial is testing

CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

Who this might be right for
D011471D064129D035683+2 more
Azienda Ospedaliero-Universitaria Careggi 46
Not applicableUnknownNCT05921812
What this trial is testing

Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Sohag University 70
Not applicableNot Yet RecruitingNCT07026851
What this trial is testing

Pilot Study to Establish a Repertoire of Megakaryocyte Markers, Quantifiable by Spectral Flow Cytometry, in Bone Marrow and Circulating in Patients Undergoing Cardiac Surgery for Bypass Grafting

Who this might be right for
Cardiac Surgery for Bypass Grafting
University Hospital, Toulouse 20
Large-scale testing (Phase 3)Ended earlyNCT00361907
What this trial is testing

Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

Who this might be right for
Diabetes Mellitus
Florida Atlantic University 105
Not applicableLooking for participantsNCT00762008
What this trial is testing

Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

Who this might be right for
Acute Decompensated Heart FailureHeart Failure
UConn Health 500
Not applicableStudy completedNCT00410449
What this trial is testing

Oxidative Stress and Hemodialysis Access Failure

Who this might be right for
End Stage Renal DiseaseHemodialysis
National Institute of Environmental Health Sciences (NIEHS) 35
Not applicableUnknownNCT03108677
What this trial is testing

Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma

Who this might be right for
Lung MetastasesOsteosarcoma
Ruijin Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06518837
What this trial is testing

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Rutgers, The State University of New Jersey 40
Not applicableLooking for participantsNCT07616401
What this trial is testing

MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

Who this might be right for
OsteoporosisMenopause
Istituto Auxologico Italiano 42
Not applicableStudy completedNCT00379704
What this trial is testing

TIFACT Study - Tissue Factor Expression by Adipose Tissue in Extremely Obese Subjects.

Who this might be right for
Obesity
Assistance Publique - Hôpitaux de Paris 85
Not applicableStudy completedNCT05074758
What this trial is testing

Characterization of the microVAScular Dysfunction in Covid-19 ARDS

Who this might be right for
ARDS, HumanCOVID-19 Acute Respiratory Distress Syndrome
Assistance Publique - Hôpitaux de Paris 39
Not applicableEnded earlyNCT00617721
What this trial is testing

Markers of Defective Membrane Remodelling in Scott-like Syndromes

Who this might be right for
Unexplained Isolated Provoked HemorrhagesFamilial Bleeding DisorderScott Syndrome
University Hospital, Strasbourg, France 29
Not applicableLooking for participantsNCT06863805
What this trial is testing

Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas

Who this might be right for
Thyroid Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 10
Not applicableStudy completedNCT01541800
What this trial is testing

Circulating microRNAs as Disease Markers in Pediatric Cancers

Who this might be right for
LeukemiaLymphomaCentral Nervous System
Ann & Robert H Lurie Children's Hospital of Chicago 20
Not applicableActive Not RecruitingNCT07795892
What this trial is testing

Circulating RNA Markers of Ventricular Arrhythmias in Remotely Monitored Patients With Post-Infarction Heart Failure and Implanted Cardioverter-Defibrillators

Who this might be right for
Heart Failure With Reduced Ejection FractionVentricular ArrhythmiaIschemic Cardiomyopathy
University of Rzeszow 57
Not applicableStudy completedNCT00500617
What this trial is testing

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

Who this might be right for
Coronary Artery DiseaseAngina PectorisChest Pain+5 more
CardioDx 4,350
Not applicableEnded earlyNCT02117440
What this trial is testing

Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer

Who this might be right for
Lung Neoplasms
Indiana University 10
Not applicableStudy completedNCT02872779
What this trial is testing

Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Circulating MarkersMetastatic Colorectal Cancer
University Hospital, Rouen 74
Next Page